Vaxess Technologies, Inc.

CAMBRIDGE, MA 02139

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $2.31MM
First Award Date 01/01/15
Most Recent Award Date 09/15/17

Key Personnel

Last Name Name Awards Contact
KOSUDA KATHRYN KOSUDA 5 Message
KLUGE JONATHAN AUGUST KLUGE 3

6 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 09/15/17 - 08/31/18

Silk-Based Biospecimen Stabilization for Exposure Assessment Project Summary/Abstract There is a critical need for a stabilization platform that can preserve biospecimen integrity, completely free of cold storage requirements. Such a technology would allow researchers, clinicians, government personnel and consumers to conduct biomonitoring in fi...

Phase 2 SBIR

Agency: National Science Foundation
Topic: BM
Budget: 10/01/16 - 09/30/18

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be to increase global access to vaccines and reduce mortality associated with infectious diseases. As an example, Rotavirus is a major cause of severe gastroenteritis among young children and lack of vaccination results in 450,000 deat...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PAR-13-327
Budget: 02/05/16 - 07/31/16

? DESCRIPTION (provided by applicant) There is a critical need for a blood sample preparation and processing method that can preserve integrity and improve downstream analysis, while being completely free of cold storage requirements. Such a technology would allow clinicians and patients to collect blood samples for cancer screening, monitor...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-ES-14-005
Budget: 06/01/15 - 05/31/16

DESCRIPTION (provided by applicant): There is a critical need for a stabilization platform that can preserve biospecimen integrity, completely free of cold storage requirements. Such a technology would allow researchers, clinicians, and government personnel to conduct biomonitoring in field conditions (i.e. without requiring visits to the outpat...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 03/01/15 - 08/31/15

DESCRIPTION (provided by applicant): This application entitled "Development of a Silk-Stabilized Inactivated Polio Vaccine" is a response to the Omnibus solicitation of the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Administration for Children and Families for Small Business Inno...

Phase 1 SBIR

Agency: National Science Foundation
Topic: BM
Budget: 01/01/15 - 12/31/15

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to increase global access to vaccines and reduce mortality associated with infectious diseases. As an example, Rotavirus is a major cause of severe gastroenteritis among young children and lack of vaccination results in 450,000 death...